Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Neovasc Inc (NVCN) NPV

Sell:4.17 CAD Buy:4.31 CAD Change: 0.07 CAD (1.64%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:4.17 CAD
Buy:4.31 CAD
Change: 0.07 CAD (1.64%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:4.17 CAD
Buy:4.31 CAD
Change: 0.07 CAD (1.64%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Contact details

Address:
Richmond, 5138-13562 Maycrest Way
RICHMOND
V6V 2J7
Canada
Telephone:
+1 (604) 2704344
Website:
https://www.neovasc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NVCN
ISIN:
CA64065J3047
Market cap:
48.12 million CAD
Shares in issue:
11.13 million
Sector:
Health Care Equipment
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Steven Rubin
    Independent Chairman of the Board
  • Fred Colen
    President, Chief Executive Officer
  • Christopher Clark
    Chief Financial Officer, Corporate Secretary
  • Bill Little
    Chief Operating Officer
  • Vicki Bebeau
    Vice President - Clinical and Regulatory Affairs
  • Aaron Chalekian
    Vice President - Product Development & Manufacturing Engineering
  • John Panton
    Vice President - Quality

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.